{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:52:15Z","timestamp":1791449535530,"version":"4.3.3"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05725-5","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:19:47Z","timestamp":1791447587000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Arbutin as a promising cardioprotective anticancer adjuvant with doxorubicin in solid Ehrlich carcinoma through targeting NEK7-dependent inflammasome\/SIRT1\/caspase-3\/oxidative stress pathways"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5863-9363","authenticated-orcid":false,"given":"Eman R.","family":"Abdelmonaem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2450-8998","authenticated-orcid":false,"given":"Salma M.","family":"Eraky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4470-0263","authenticated-orcid":false,"given":"Laila A.","family":"Eissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"issue":"4","key":"5725_CR1","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jcrpr.2017.07.001","volume":"4","author":"SH Hassanpour","year":"2017","unstructured":"Hassanpour SH, Dehghani M (2017) Review of cancer from perspective of molecular. J Cancer Res Pract 4(4):127\u2013129. https:\/\/doi.org\/10.1016\/j.jcrpr.2017.07.001","journal-title":"J Cancer Res Pract"},{"key":"5725_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.11.045","author":"AF Yu","year":"2019","unstructured":"Yu AF, Chan AT, Steingart RM (2019) Cardiac magnetic resonance and cardio-oncology: does T 2 signal the end of anthracycline cardiotoxicity? J Am Coll Cardiol. https:\/\/doi.org\/10.1016\/j.jacc.2018.11.045","journal-title":"J Am Coll Cardiol"},{"key":"5725_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/J.LFS.2021.119527","volume":"278","author":"S Sritharan","year":"2021","unstructured":"Sritharan S, Sivalingam N (2021) A comprehensive review on time-tested anticancer drug doxorubicin. Life Sci 278:119527. https:\/\/doi.org\/10.1016\/J.LFS.2021.119527","journal-title":"Life Sci"},{"key":"5725_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2018.06.005","author":"AZ Luu","year":"2018","unstructured":"Luu AZ, Chowdhury B, Al-Omran M, Teoh H, Hess DA, Verma S (2018) Role of endothelium in doxorubicin-induced cardiomyopathy. JACC: Basic Transl Sci. https:\/\/doi.org\/10.1016\/j.jacbts.2018.06.005","journal-title":"JACC: Basic Transl Sci"},{"key":"5725_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111708","author":"PS Rawat","year":"2021","unstructured":"Rawat PS, Jaiswal A, Khurana A, Bhatti JS, Navik U (2021) Doxorubicin-induced cardiotoxicity: an update on the molecular mechanism and novel therapeutic strategies for effective management. Biomed Pharmacother. https:\/\/doi.org\/10.1016\/j.biopha.2021.111708","journal-title":"Biomed Pharmacother"},{"key":"5725_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/J.YJMCC.2019.08.009","volume":"136","author":"L Meng","year":"2019","unstructured":"Meng L et al (2019) Doxorubicin induces cardiomyocyte pyroptosis via the TINCR-mediated posttranscriptional stabilization of NLR family pyrin domain containing 3. J Mol Cell Cardiol 136:15\u201326. https:\/\/doi.org\/10.1016\/J.YJMCC.2019.08.009","journal-title":"J Mol Cell Cardiol"},{"key":"5725_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12860-022-00454-1","author":"S Hwang","year":"2022","unstructured":"Hwang S, Kim SH, Yoo KH, Chung MH, Lee JW, Son KH (2022) Exogenous 8-hydroxydeoxyguanosine attenuates doxorubicin-induced cardiotoxicity by decreasing pyroptosis in H9c2 cardiomyocytes. BMC Mol Cell Biol. https:\/\/doi.org\/10.1186\/s12860-022-00454-1","journal-title":"BMC Mol Cell Biol"},{"key":"5725_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.991044","author":"Y Pan","year":"2022","unstructured":"Pan Y et al (2022) Pyroptosis in development, inflammation and disease. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.991044","journal-title":"Front Immunol"},{"key":"5725_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-022-00998-3","author":"Y Wu","year":"2022","unstructured":"Wu Y et al (2022) Cell pyroptosis in health and inflammatory diseases. Cell Death Discov. https:\/\/doi.org\/10.1038\/s41420-022-00998-3","journal-title":"Cell Death Discov"},{"key":"5725_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1173235","author":"R Chai","year":"2023","unstructured":"Chai R, Li Y, Shui L, Ni L, Zhang A (2023) The role of pyroptosis in inflammatory diseases. Front Media SA. https:\/\/doi.org\/10.3389\/fcell.2023.1173235","journal-title":"Front Media SA"},{"issue":"11","key":"5725_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ph14111188","volume":"14","author":"AM Kabel","year":"2021","unstructured":"Kabel AM, Salama SA, Adwas AA, Estfanous RS (2021) Targeting oxidative stress, NLRP3 inflammasome, and autophagy by fraxetin to combat doxorubicin-induced cardiotoxicity. Pharmaceuticals (Basel) 14(11):1188. https:\/\/doi.org\/10.3390\/ph14111188","journal-title":"Pharmaceuticals (Basel)"},{"key":"5725_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1883-8","author":"X Xia","year":"2019","unstructured":"Xia X et al (2019) The role of pyroptosis in cancer: pro-cancer or pro-\u2018host\u2019? Cell Death Dis. https:\/\/doi.org\/10.1038\/s41419-019-1883-8","journal-title":"Cell Death Dis"},{"issue":"7590","key":"5725_CR13","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/nature16959","volume":"530","author":"Y He","year":"2016","unstructured":"He Y, Zeng MY, Yang D, Motro B, N\u00fa\u00f1ez G (2016) NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature 530(7590):354\u2013357. https:\/\/doi.org\/10.1038\/nature16959","journal-title":"Nature"},{"key":"5725_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01257-8","author":"QJ Wu","year":"2022","unstructured":"Wu QJ et al (2022) The sirtuin family in health and disease. Signal Transduct Target Ther. https:\/\/doi.org\/10.1038\/s41392-022-01257-8","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"5725_CR15","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1161\/01.RES.0000267723.65696.4a","volume":"100","author":"RR Alcendor","year":"2007","unstructured":"Alcendor RR et al (2007) Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ Res 100(10):1512\u20131521. https:\/\/doi.org\/10.1161\/01.RES.0000267723.65696.4a","journal-title":"Circ Res"},{"issue":"11","key":"5725_CR16","first-page":"5233","volume":"11","author":"N Yousafzai","year":"2021","unstructured":"Yousafzai N, Jin H, Ullah M, Wang X (2021) Recent advances of SIRT1 and implications in chemotherapeutics resistance in cancer. Am J Cancer Res 11(11):5233","journal-title":"Am J Cancer Res"},{"key":"5725_CR17","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/B978-0-323-90052-2.00045-7","volume-title":"Treatments, nutraceuticals, supplements, and herbal medicine in neurological disorders","author":"M Ghasemi-Kasman","year":"2023","unstructured":"Ghasemi-Kasman M, Bali HY, Abdi S (2023) Arbutin as a natural soluble glycosylated phenol and usage in neuroinflammation. Treatments, nutraceuticals, supplements, and herbal medicine in neurological disorders. Elsevier, Amsterdam, pp 525\u2013539. https:\/\/doi.org\/10.1016\/B978-0-323-90052-2.00045-7"},{"key":"5725_CR18","doi-asserted-by":"publisher","DOI":"10.17219\/ACEM\/133493","author":"C Ma","year":"2021","unstructured":"Ma C, Zhang D, Ma Q, Liu Y, Yang Y (2021) Arbutin inhibits inflammation and apoptosis by enhancing autophagy via SIRT1. Adv Clin Exp Med. https:\/\/doi.org\/10.17219\/ACEM\/133493","journal-title":"Adv Clin Exp Med"},{"key":"5725_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ph17070909","author":"HH Arab","year":"2024","unstructured":"Arab HH et al (2024) Targeting JAK2\/STAT3, NLRP3\/Caspase-1, and PK2\/PKR2 pathways with arbutin ameliorates lead acetate-induced testicular injury in rats. Pharmaceuticals (Basel). https:\/\/doi.org\/10.3390\/ph17070909","journal-title":"Pharmaceuticals (Basel)"},{"key":"5725_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118578","author":"IB Feitosa","year":"2021","unstructured":"Feitosa IB, Mori B, Teles CBG, Costa A (2021) What are the immune responses during the growth of Ehrlich\u2019s tumor in ascitic and solid form? Life Sci. https:\/\/doi.org\/10.1016\/j.lfs.2020.118578","journal-title":"Life Sci"},{"key":"5725_CR21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/J.LFS.2016.08.009","volume":"162","author":"FTT Frajacomo","year":"2016","unstructured":"Frajacomo FTT et al (2016) Solid Ehrlich carcinoma reproduces functional and biological characteristics of cancer cachexia. Life Sci 162:47\u201353. https:\/\/doi.org\/10.1016\/J.LFS.2016.08.009","journal-title":"Life Sci"},{"issue":"1","key":"5725_CR22","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1080\/2314808x.2019.1682331","volume":"6","author":"NA Abd Elrazik","year":"2019","unstructured":"Abd Elrazik NA, El-Mesery M, El-Karef A, Eissa LA, El Gayar AM (2019) Chlorogenic acid potentiates antitumor effect of doxorubicin through upregulation of death receptors in solid Ehrlich carcinoma model in mice. Egypt J Basic Appl Sci 6(1):158\u2013172. https:\/\/doi.org\/10.1080\/2314808x.2019.1682331","journal-title":"Egypt J Basic Appl Sci"},{"key":"5725_CR23","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8296451","author":"BM Barakat","year":"2018","unstructured":"Barakat BM, Ahmed HI, Bahr HI, Elbahaie AM (2018) Protective effect of boswellic acids against doxorubicin-induced hepatotoxicity: impact on Nrf2\/HO-1 defense pathway. Oxid Med Cell Longev. https:\/\/doi.org\/10.1155\/2018\/8296451","journal-title":"Oxid Med Cell Longev"},{"key":"5725_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/J.NEUINT.2021.105217","volume":"151","author":"M Kumar","year":"2021","unstructured":"Kumar M, Kumar A, Sindhu RK, Kushwah AS (2021) Arbutin attenuates monosodium L-glutamate induced neurotoxicity and cognitive dysfunction in rats. Neurochem Int 151:105217. https:\/\/doi.org\/10.1016\/J.NEUINT.2021.105217","journal-title":"Neurochem Int"},{"key":"5725_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2020.09.002","author":"A Upadhyay","year":"2021","unstructured":"Upadhyay A (2021) Cancer: an unknown territory; rethinking before going ahead. Genes Dis. https:\/\/doi.org\/10.1016\/j.gendis.2020.09.002","journal-title":"Genes Dis"},{"key":"5725_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz781","author":"J Herrmann","year":"2019","unstructured":"Herrmann J (2019) From trends to transformation: where cardio-oncology is to make a difference. Eur Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehz781","journal-title":"Eur Heart J"},{"key":"5725_CR27","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1152\/ajpheart.00720.2015.-Cancer","volume":"310","author":"KT Murphy","year":"2016","unstructured":"Murphy KT (2016) The pathogenesis and treatment of cardiac atrophy in cancer cachexia. Am J Physiol Heart Circ Physiol 310:466\u2013477. https:\/\/doi.org\/10.1152\/ajpheart.00720.2015.-Cancer","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"5725_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/182872","author":"JM Argiles","year":"2015","unstructured":"Argiles JM, Stemmler B, Lopez-Soriano FJ, Busquets S (2015) Nonmuscle tissues contribution to cancer cachexia. Mediators Inflamm. https:\/\/doi.org\/10.1155\/2015\/182872","journal-title":"Mediators Inflamm"},{"key":"5725_CR29","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1974.02110230080012Noabstractavailable","author":"CB Pratt","year":"1974","unstructured":"Pratt CB, Shanks EC (1974) Doxorubicin in treatment of malignant solid tumors in children. Am J Dis Child. https:\/\/doi.org\/10.1001\/archpedi.1974.02110230080012Noabstractavailable","journal-title":"Am J Dis Child"},{"issue":"4","key":"5725_CR30","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3322\/caac.21341","volume":"66","author":"G Curigliano","year":"2016","unstructured":"Curigliano G et al (2016) Cardiotoxicity of anticancer treatments: epidemiology, detection, and management. CA Cancer J Clin 66(4):309\u2013325. https:\/\/doi.org\/10.3322\/caac.21341","journal-title":"CA Cancer J Clin"},{"key":"5725_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01398-5","author":"MJ Iqbal","year":"2024","unstructured":"Iqbal MJ et al (2024) Interplay of oxidative stress, cellular communication and signaling pathways in cancer. Cell Commun Signal. https:\/\/doi.org\/10.1186\/s12964-023-01398-5","journal-title":"Cell Commun Signal"},{"issue":"2","key":"5725_CR32","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/J.CCELL.2020.06.001","volume":"38","author":"JD Hayes","year":"2020","unstructured":"Hayes JD, Dinkova-Kostova AT, Tew KD (2020) Oxidative stress in cancer. Cancer Cell 38(2):167\u2013197. https:\/\/doi.org\/10.1016\/J.CCELL.2020.06.001","journal-title":"Cancer Cell"},{"key":"5725_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2010.09.006","author":"S Reuter","year":"2010","unstructured":"Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB (2010) Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2010.09.006","journal-title":"Free Radic Biol Med"},{"key":"5725_CR34","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/5162687","author":"MA Aldubayan","year":"2019","unstructured":"Aldubayan MA, Elgharabawy RM, Ahmed AS, Tousson E (2019) Antineoplastic activity and curative role of avenanthramides against the growth of Ehrlich solid tumors in mice. Oxid Med Cell Longev. https:\/\/doi.org\/10.1155\/2019\/5162687","journal-title":"Oxid Med Cell Longev"},{"key":"5725_CR35","doi-asserted-by":"publisher","first-page":"871","DOI":"10.2147\/OPTH.S287747","volume":"15","author":"RP Maurya","year":"2021","unstructured":"Maurya RP et al (2021) Serum malondialdehyde as a biomarker of oxidative stress in patients with primary ocular carcinoma: Impact on response to chemotherapy. Clin Ophthalmol 15:871\u2013879. https:\/\/doi.org\/10.2147\/OPTH.S287747","journal-title":"Clin Ophthalmol"},{"key":"5725_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112376","author":"SA Helmy","year":"2022","unstructured":"Helmy SA, El-Mofty S, El Gayar AM, El-Sherbiny IM, El-Far YM (2022) Novel doxorubicin\/folate-targeted trans-ferulic acid-loaded doxorubicin\/folate-targeted trans-ferulic acid-loaded PLGA nanoparticles combination: in-vivo superiority over standard chemotherapeutic regimen for breast cancer treatment. Biomed Pharmacother. https:\/\/doi.org\/10.1016\/j.biopha.2021.112376","journal-title":"Biomed Pharmacother"},{"key":"5725_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103753","author":"X Guo","year":"2025","unstructured":"Guo X et al (2025) 5-Oxoproline prevents doxorubicin-induced cardiotoxicity and tumor growth. Redox Biol. https:\/\/doi.org\/10.1016\/j.redox.2025.103753","journal-title":"Redox Biol"},{"key":"5725_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/J.LFS.2023.121612","volume":"321","author":"MS Abduh","year":"2023","unstructured":"Abduh MS et al (2023) Arbutin ameliorates hyperglycemia, dyslipidemia and oxidative stress and modulates adipocytokines and PPAR\u03b3 in high-fat diet\/streptozotocin-induced diabetic rats. Life Sci 321:121612. https:\/\/doi.org\/10.1016\/J.LFS.2023.121612","journal-title":"Life Sci"},{"key":"5725_CR39","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431X2024e13306","author":"KA Ahmed","year":"2024","unstructured":"Ahmed KA et al (2024) Chemoprotective effect of arbutin on azoxymethane-induced aberrant crypt foci in rat colon via modulation of PCNA\/Bax protein. Braz J Med Biol Res. https:\/\/doi.org\/10.1590\/1414-431X2024e13306","journal-title":"Braz J Med Biol Res"},{"key":"5725_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/biom10101429","author":"L Kennedy","year":"2020","unstructured":"Kennedy L, Sandhu JK, Harper ME, Cuperlovic-culf M (2020) Role of glutathione in cancer: from mechanisms to therapies. Biomolecules. https:\/\/doi.org\/10.3390\/biom10101429","journal-title":"Biomolecules"},{"key":"5725_CR41","unstructured":"Abdalla MY (2011) Glutathione as potential target for cancer therapy; more or less is good? (Mini-Review). https:\/\/jjbs.hu.edu.jo\/files\/v4n3\/Paper_number1_modified-Final.pdf. Accessed 18 Jun 2026"},{"key":"5725_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-00886-5","author":"BR Sharma","year":"2021","unstructured":"Sharma BR, Kanneganti TD (2021) NLRP3 inflammasome in cancer and metabolic diseases. Nat Immunol. https:\/\/doi.org\/10.1038\/s41590-021-00886-5","journal-title":"Nat Immunol"},{"key":"5725_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0123-y","author":"R Karki","year":"2019","unstructured":"Karki R, Kanneganti TD (2019) Diverging inflammasome signals in tumorigenesis and potential targeting. Nat Rev Cancer. https:\/\/doi.org\/10.1038\/s41568-019-0123-y","journal-title":"Nat Rev Cancer"},{"key":"5725_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/srep36107","author":"B Guo","year":"2016","unstructured":"Guo B, Fu S, Zhang J, Liu B, Li Z (2016) Targeting inflammasome\/IL-1 pathways for cancer immunotherapy. Sci Rep. https:\/\/doi.org\/10.1038\/srep36107","journal-title":"Sci Rep"},{"key":"5725_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.635774","author":"L Wang","year":"2021","unstructured":"Wang L, Qin X, Liang J, Ge P (2021) Induction of pyroptosis: a promising strategy for cancer treatment. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2021.635774","journal-title":"Front Oncol"},{"issue":"17","key":"5725_CR46","doi-asserted-by":"publisher","first-page":"8159","DOI":"10.1111\/jcmm.16574","volume":"25","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Zhang H, Li D, Zhou X, Qin Q, Zhang Q (2021) Caspase-3-mediated GSDME induced pyroptosis in breast cancer cells through the ROS\/JNK signalling pathway. J Cell Mol Med 25(17):8159\u20138168. https:\/\/doi.org\/10.1111\/jcmm.16574","journal-title":"J Cell Mol Med"},{"key":"5725_CR47","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.5.147Abstract","author":"C-X Deng","year":"2009","unstructured":"Deng C-X (2009) SIRT1, Is it a tumor promoter or tumor suppressor? Int J Biol Sci. https:\/\/doi.org\/10.7150\/ijbs.5.147Abstract","journal-title":"Int J Biol Sci"},{"key":"5725_CR48","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2023.2235770","author":"XW Wang","year":"2023","unstructured":"Wang XW, Jiang YH, Ye W, Shao CF, Xie JJ, Li X (2023) SIRT1 promotes the progression and chemoresistance of colorectal cancer through the p53\/miR-101\/KPNA3 axis. Cancer Biol Ther. https:\/\/doi.org\/10.1080\/15384047.2023.2235770","journal-title":"Cancer Biol Ther"},{"issue":"11","key":"5725_CR49","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.7150\/jca.24275","volume":"9","author":"X Jin","year":"2018","unstructured":"Jin X et al (2018) SIRT1 promotes formation of breast cancer through modulating Akt activity. J Cancer 9(11):2012\u20132023. https:\/\/doi.org\/10.7150\/jca.24275","journal-title":"J Cancer"},{"key":"5725_CR50","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/2374615","author":"MD Molla","year":"2020","unstructured":"Molla MD, Dessie G, Akalu Y, Ayelign B (2020) Hepatocellular Expression of SIRT1 and Its Effect on Hepatocellular Carcinoma Progression: A Future Therapeutic Perspective. Hindawi Ltd. https:\/\/doi.org\/10.1155\/2020\/2374615","journal-title":"Hindawi Ltd"},{"key":"5725_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117176","author":"W Dong","year":"2024","unstructured":"Dong W et al (2024) SIRT1: a novel regulator in colorectal cancer. Biomed Pharmacother. https:\/\/doi.org\/10.1016\/j.biopha.2024.117176","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"5725_CR52","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/J.BBRC.2018.05.164","volume":"502","author":"Y Xu","year":"2018","unstructured":"Xu Y, Qin Q, Chen R, Wei C, Mo Q (2018) SIRT1 promotes proliferation, migration, and invasion of breast cancer cell line MCF-7 by upregulating DNA polymerase delta1 (POLD1). Biochem Biophys Res Commun 502(3):351\u2013357. https:\/\/doi.org\/10.1016\/J.BBRC.2018.05.164","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"5725_CR53","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/ncb1468","volume":"8","author":"C Wang","year":"2006","unstructured":"Wang C et al (2006) Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage. Nat Cell Biol 8(9):1025\u20131031. https:\/\/doi.org\/10.1038\/ncb1468","journal-title":"Nat Cell Biol"},{"issue":"11","key":"5725_CR54","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/ncb868","volume":"4","author":"Z Nahle","year":"2002","unstructured":"Nahle Z et al (2002) Direct coupling of the cell cycle and cell death machinery by E2F. Nat Cell Biol 4(11):28\u201334. https:\/\/doi.org\/10.1038\/ncb868","journal-title":"Nat Cell Biol"},{"issue":"3","key":"5725_CR55","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1042\/BJ20070151","volume":"407","author":"S Wong","year":"2007","unstructured":"Wong S, Weber JD (2007) Deacetylation of the retinoblastoma tumour suppressor protein by SIRT1. Biochem J 407(3):451\u2013460. https:\/\/doi.org\/10.1042\/BJ20070151","journal-title":"Biochem J"},{"key":"5725_CR56","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2024.5708","author":"Q Kong","year":"2025","unstructured":"Kong Q et al (2025) Induction of ferroptosis by SIRT1 knockdown alleviates cytarabine resistance in acute myeloid leukemia by activating the HMGB1\/ACSL4 pathway. Int J Oncol. https:\/\/doi.org\/10.3892\/ijo.2024.5708","journal-title":"Int J Oncol"},{"issue":"4","key":"5725_CR57","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.molcel.2012.03.024","volume":"46","author":"Z Lin","year":"2012","unstructured":"Lin Z et al (2012) USP22 antagonizes p53 transcriptional activation by deubiquitinating Sirt1 to suppress cell apoptosis and is required for mouse embryonic development. Mol Cell 46(4):484\u2013494. https:\/\/doi.org\/10.1016\/j.molcel.2012.03.024","journal-title":"Mol Cell"},{"issue":"5","key":"5725_CR58","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/onc.2012.83","volume":"32","author":"Z Wang","year":"2013","unstructured":"Wang Z, Yuan H, Roth M, Stark JM, Bhatia R, Chen WY (2013) SIRT1 deacetylase promotes acquisition of genetic mutations for drug resistance in CML cells. Oncogene 32(5):589\u2013598. https:\/\/doi.org\/10.1038\/onc.2012.83","journal-title":"Oncogene"},{"issue":"4","key":"5725_CR59","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.ccr.2008.09.001","volume":"14","author":"RH Wang","year":"2008","unstructured":"Wang RH et al (2008) Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. Cancer Cell 14(4):312\u2013323. https:\/\/doi.org\/10.1016\/j.ccr.2008.09.001","journal-title":"Cancer Cell"},{"key":"5725_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002020","author":"R Firestein","year":"2008","unstructured":"Firestein R et al (2008) The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0002020","journal-title":"PLoS One"},{"issue":"5","key":"5725_CR61","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.cell.2008.10.025","volume":"135","author":"P Oberdoerffer","year":"2008","unstructured":"Oberdoerffer P et al (2008) SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging. Cell 135(5):907\u2013918. https:\/\/doi.org\/10.1016\/j.cell.2008.10.025","journal-title":"Cell"},{"issue":"7","key":"5725_CR62","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/s12276-020-0465-2","volume":"52","author":"TY Jung","year":"2020","unstructured":"Jung TY et al (2020) Deacetylation by SIRT1 promotes the tumor-suppressive activity of HINT1 by enhancing its binding capacity for \u03b2-catenin or MITF in colon cancer and melanoma cells. Exp Mol Med 52(7):1075\u20131089. https:\/\/doi.org\/10.1038\/s12276-020-0465-2","journal-title":"Exp Mol Med"},{"issue":"1","key":"5725_CR63","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.molcel.2008.09.011","volume":"32","author":"RH Wang","year":"2008","unstructured":"Wang RH et al (2008) Interplay among BRCA1, SIRT1, and survivin during BRCA1-associated tumorigenesis. Mol Cell 32(1):11\u201320. https:\/\/doi.org\/10.1016\/j.molcel.2008.09.011","journal-title":"Mol Cell"},{"issue":"5","key":"5725_CR64","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1158\/2326-6066.CIR-17-0036","volume":"6","author":"C Porta","year":"2018","unstructured":"Porta C et al (2018) Protumor steering of cancer inflammation by p50 nf-kb enhances colorectal cancer progression. Cancer Immunol Res 6(5):578\u2013593. https:\/\/doi.org\/10.1158\/2326-6066.CIR-17-0036","journal-title":"Cancer Immunol Res"},{"issue":"5","key":"5725_CR65","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.32604\/BIOCELL.2021.015464","volume":"45","author":"AF El-Kott","year":"2021","unstructured":"El-Kott AF et al (2021) Exendin-4 inhibits the survival and invasiveness of two colorectal cancer cell lines via suppressing GS3K\u03b2\/\u03b2-catenin\/NF-\u03baB axis through activating SIRT1. Biocell 45(5):1337\u20131353. https:\/\/doi.org\/10.32604\/BIOCELL.2021.015464","journal-title":"Biocell"},{"key":"5725_CR66","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/J.CANLET.2017.09.001","volume":"409","author":"LN Sun","year":"2017","unstructured":"Sun LN et al (2017) SIRT1 suppresses colorectal cancer metastasis by transcriptional repression of miR-15b-5p. Cancer Lett 409:104\u2013115. https:\/\/doi.org\/10.1016\/J.CANLET.2017.09.001","journal-title":"Cancer Lett"},{"issue":"4","key":"5725_CR67","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/J.STEM.2014.08.001","volume":"15","author":"L Li","year":"2014","unstructured":"Li L et al (2014) SIRT1 activation by a c-MYC oncogenic network promotes the maintenance and drug resistance of human FLT3-ITD acute myeloid leukemia stem cells. Cell Stem Cell 15(4):431\u2013446. https:\/\/doi.org\/10.1016\/J.STEM.2014.08.001","journal-title":"Cell Stem Cell"},{"issue":"2","key":"5725_CR68","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1083\/jcb.200809167","volume":"185","author":"J Yuan","year":"2009","unstructured":"Yuan J, Minter-Dykhouse K, Lou Z (2009) A c-Myc-SIRT1 feedback loop regulates cell growth and transformation. J Cell Biol 185(2):203\u2013211. https:\/\/doi.org\/10.1083\/jcb.200809167","journal-title":"J Cell Biol"},{"key":"5725_CR69","doi-asserted-by":"publisher","first-page":"110148","DOI":"10.1016\/J.INTIMP.2023.110148","volume":"119","author":"NE El-Ashmawy","year":"2023","unstructured":"El-Ashmawy NE, Khedr EG, Khedr NF, El-Adawy SA (2023) Suppression of epithelial-mesenchymal transition and SIRT1\/AKT signaling pathway in breast cancer by montelukast. Int Immunopharmacol 119:110148. https:\/\/doi.org\/10.1016\/J.INTIMP.2023.110148","journal-title":"Int Immunopharmacol"},{"key":"5725_CR70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0102831","author":"S Hirai","year":"2014","unstructured":"Hirai S et al (2014) Antitumor effects of a sirtuin inhibitor, tenovin-6, against gastric cancer cells via death receptor 5 up-regulation. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0102831","journal-title":"PLoS One"},{"key":"5725_CR71","doi-asserted-by":"publisher","first-page":"105985","DOI":"10.1016\/J.TIV.2024.105985","volume":"104","author":"E Terzi","year":"2025","unstructured":"Terzi E, Oz-Bedir BE, Ercan E, \u00d6zdemir-Sanci T, Jafarova S, Aydin T (2025) \u03b2-Arbutin and cisplatin: a combined approach to modulating apoptosis, cell viability, and migration in bladder cancer cells. Toxicol Vitro 104:105985. https:\/\/doi.org\/10.1016\/J.TIV.2024.105985","journal-title":"Toxicol Vitro"},{"issue":"4","key":"5725_CR72","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3906\/biy-1912-71","volume":"44","author":"R Khodadust","year":"2020","unstructured":"Khodadust R, Alpsoy A, \u00dcnsoy G, G\u00fcnd\u00fcz U (2020) Poly (I:C)-and doxorubicin-loaded magnetic dendrimeric nanoparticles affect the apoptosis-related gene expressions in mcf-7 cells. Turk J Biol 44(4):133\u2013144. https:\/\/doi.org\/10.3906\/biy-1912-71","journal-title":"Turk J Biol"},{"issue":"7","key":"5725_CR73","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s12012-021-09644-3","volume":"21","author":"AZ Ahmed","year":"2021","unstructured":"Ahmed AZ, Mumbrekar KD, Satyam SM, Shetty P, D\u2019Souza MR, Singh VK (2021) Chia seed oil ameliorates doxorubicin-induced cardiotoxicity in female Wistar rats: an electrocardiographic, biochemical and histopathological approach. Cardiovasc Toxicol 21(7):533\u2013542. https:\/\/doi.org\/10.1007\/s12012-021-09644-3","journal-title":"Cardiovasc Toxicol"},{"issue":"6","key":"5725_CR74","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s00210-023-02382-z","volume":"396","author":"PL Dulf","year":"2023","unstructured":"Dulf PL et al (2023) Doxorubicin-induced acute cardiotoxicity is associated with increased oxidative stress, autophagy, and inflammation in a murine model. Naunyn Schmiedebergs Arch Pharmacol 396(6):1105\u20131115. https:\/\/doi.org\/10.1007\/s00210-023-02382-z","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"5725_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-52356-1.00017-7","author":"ZF Issa","year":"2019","unstructured":"Issa ZF, Miller JM, Zipes DP (2019) Atrioventricular nodal reentrant tachycardia. Clin Arrhythmology Electrophysiol. https:\/\/doi.org\/10.1016\/B978-0-323-52356-1.00017-7","journal-title":"Clin Arrhythmology Electrophysiol"},{"key":"5725_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccep.2021.06.007","author":"LR Jackson","year":"2021","unstructured":"Jackson LR, Ugowe F (2021) Epidemiology and outcomes associated with PR prolongation. Card Electrophysiol Clin. https:\/\/doi.org\/10.1016\/j.ccep.2021.06.007","journal-title":"Card Electrophysiol Clin"},{"issue":"2","key":"5725_CR77","doi-asserted-by":"publisher","first-page":"052","DOI":"10.4172\/1948-5956.1000184","volume":"5","author":"MS Oliveira","year":"2013","unstructured":"Oliveira MS et al (2013) Doxorubicin cardiotoxicity and cardiac function improvement after stem cell therapy diagnosed by strain echocardiography. J Cancer Sci Ther 5(2):052\u2013057. https:\/\/doi.org\/10.4172\/1948-5956.1000184","journal-title":"J Cancer Sci Ther"},{"key":"5725_CR78","doi-asserted-by":"publisher","DOI":"10.1093\/ehjimp\/qyaf006","author":"S Haesen","year":"2025","unstructured":"Haesen S, Steegen L, Deluyker D, Bito V (2025) Comprehensive transthoracic echocardiographic evaluation of doxorubicin-induced cardiotoxicity: a multimodal imaging approach in an animal model. Eur Heart J - Imaging Methods Pract. https:\/\/doi.org\/10.1093\/ehjimp\/qyaf006","journal-title":"Eur Heart J - Imaging Methods Pract"},{"issue":"1","key":"5725_CR79","doi-asserted-by":"publisher","first-page":"55","DOI":"10.22092\/ARI.2019.116862.1177","volume":"75","author":"H Babaei","year":"2020","unstructured":"Babaei H et al (2020) Ultrastructural and echocardiographic assessment of chronic doxorubicin-induced cardiotoxicity in rats. Arch Razi Inst 75(1):55\u201362. https:\/\/doi.org\/10.22092\/ARI.2019.116862.1177","journal-title":"Arch Razi Inst"},{"issue":"1","key":"5725_CR80","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S1734-1140(09)70018-0","volume":"61","author":"T \u0160im\u016fnek","year":"2009","unstructured":"\u0160im\u016fnek T, \u0160t\u011brba M, Popelov\u00e1 O, Adamcov\u00e1 M, Hrdina R, Ger\u0161i V (2009) Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron. Pharmacol Rep 61(1):154\u2013171. https:\/\/doi.org\/10.1016\/S1734-1140(09)70018-0","journal-title":"Pharmacol Rep"},{"issue":"7","key":"5725_CR81","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1089\/ars.2019.7929","volume":"34","author":"S Antonucci","year":"2021","unstructured":"Antonucci S et al (2021) The determining role of mitochondrial reactive oxygen species generation and monoamine oxidase activity in doxorubicin-induced cardiotoxicity. Antioxid Redox Signal 34(7):531\u2013550. https:\/\/doi.org\/10.1089\/ars.2019.7929","journal-title":"Antioxid Redox Signal"},{"issue":"3","key":"5725_CR82","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.3892\/mmr.2014.2384","volume":"10","author":"SE Al-Harthi","year":"2014","unstructured":"Al-Harthi SE et al (2014) Amelioration of doxorubicin-induced cardiotoxicity by resveratrol. Mol Med Rep 10(3):1455\u20131460. https:\/\/doi.org\/10.3892\/mmr.2014.2384","journal-title":"Mol Med Rep"},{"key":"5725_CR83","doi-asserted-by":"publisher","first-page":"111732","DOI":"10.1016\/J.NUT.2022.111732","volume":"102","author":"SRA El-Ela","year":"2022","unstructured":"El-Ela SRA, Zaghloul RA, Eissa LA (2022) Promising cardioprotective effect of baicalin in doxorubicin-induced cardiotoxicity through targeting toll-like receptor 4\/nuclear factor-\u03baB and Wnt\/\u03b2-catenin pathways. Nutrition 102:111732. https:\/\/doi.org\/10.1016\/J.NUT.2022.111732","journal-title":"Nutrition"},{"key":"5725_CR84","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3530296","author":"MA Aldubayan","year":"2020","unstructured":"Aldubayan MA (2020) Evaluation of the cardiac protection conferred by proanthocyanidins in grape seeds against development of ehrlich solid tumors in mice. Biomed Res Int. https:\/\/doi.org\/10.1155\/2020\/3530296","journal-title":"Biomed Res Int"},{"key":"5725_CR85","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1152\/ajpheart.00056","volume":"317","author":"ZT Dargani","year":"2019","unstructured":"Dargani ZT, Singla DK (2019) Embryonic stem cell-derived exosomes inhibit doxorubicin-induced TLR4-NLRP3-mediated cell death-pyroptosis. Am J Physiol Heart Circ Physiol 317:460\u2013471. https:\/\/doi.org\/10.1152\/ajpheart.00056","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"5725_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03614-x","author":"E Christidi","year":"2021","unstructured":"Christidi E, Brunham LR (2021) Regulated cell death pathways in doxorubicin-induced cardiotoxicity. Cell Death Dis. https:\/\/doi.org\/10.1038\/s41419-021-03614-x","journal-title":"Cell Death Dis"},{"key":"5725_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112133","author":"L Zhang","year":"2021","unstructured":"Zhang L et al (2021) MCC950 attenuates doxorubicin-induced myocardial injury in vivo and in vitro by inhibiting NLRP3-mediated pyroptosis. Biomed Pharmacother. https:\/\/doi.org\/10.1016\/j.biopha.2021.112133","journal-title":"Biomed Pharmacother"},{"key":"5725_CR88","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.redox.2017.05.027","volume":"13","author":"SH Chan","year":"2017","unstructured":"Chan SH et al (2017) SIRT1 inhibition causes oxidative stress and inflammation in patients with coronary artery disease. Redox Biol 13:301\u2013309. https:\/\/doi.org\/10.1016\/j.redox.2017.05.027","journal-title":"Redox Biol"},{"issue":"9","key":"5725_CR89","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/J.BCP.2013.02.015","volume":"85","author":"MJ Zarzuelo","year":"2013","unstructured":"Zarzuelo MJ et al (2013) SIRT1 inhibits NADPH oxidase activation and protects endothelial function in the rat aorta: implications for vascular aging. Biochem Pharmacol 85(9):1288\u20131296. https:\/\/doi.org\/10.1016\/J.BCP.2013.02.015","journal-title":"Biochem Pharmacol"},{"key":"5725_CR90","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1152\/ajpheart.00587.2011.-Overex","volume":"301","author":"SM Nadtochiy","year":"2011","unstructured":"Nadtochiy SM et al (2011) SIRT1-mediated acute cardioprotection. J Physiol Heart Circ Physiol 301:1506\u20131512. https:\/\/doi.org\/10.1152\/ajpheart.00587.2011.-Overex","journal-title":"J Physiol Heart Circ Physiol"},{"issue":"10","key":"5725_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/1414-431x20209849","volume":"53","author":"X Yu","year":"2020","unstructured":"Yu X, Zheng J, Cai T, Wang Z, Zhu G (2020) Testosterone antagonizes paraquat-induced cardiomyocyte senescence via the miGF-1\/SIRT1 signaling pathway. Braz J Med Biol Res 53(10):1\u20139. https:\/\/doi.org\/10.1590\/1414-431x20209849","journal-title":"Braz J Med Biol Res"},{"key":"5725_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102310","author":"JA Wang","year":"2022","unstructured":"Wang JA et al (2022) Cardiac SIRT1 ameliorates doxorubicin-induced cardiotoxicity by targeting sestrin 2. Redox Biol. https:\/\/doi.org\/10.1016\/j.redox.2022.102310","journal-title":"Redox Biol"},{"key":"5725_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114591","author":"W Zhang","year":"2023","unstructured":"Zhang W, Wang X, Tang Y, Huang C (2023) Melatonin alleviates doxorubicin-induced cardiotoxicity via inhibiting oxidative stress, pyroptosis and apoptosis by activating Sirt1\/Nrf2 pathway. Biomed Pharmacother. https:\/\/doi.org\/10.1016\/j.biopha.2023.114591","journal-title":"Biomed Pharmacother"},{"key":"5725_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252212376","author":"S Zhang","year":"2024","unstructured":"Zhang S et al (2024) Doxorubicin-induced cardiotoxicity through SIRT1 loss potentiates overproduction of exosomes in cardiomyocytes. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms252212376","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5725_CR95","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1254\/jphs.FP0050980","volume":"101","author":"M Ueno","year":"2006","unstructured":"Ueno M et al (2006) Doxorubicin induces apoptosis by activation of caspase-3 in cultured cardiomyocytes in vitro and rat cardiac ventricles in vivo. J Pharmacol Sci 101(2):151\u2013158. https:\/\/doi.org\/10.1254\/jphs.FP0050980","journal-title":"J Pharmacol Sci"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05725-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05725-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05725-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:19:50Z","timestamp":1791447590000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05725-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":95,"alternative-id":["5725"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05725-5","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]},"assertion":[{"value":"23 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}